These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 16300295

  • 1. [Gaucher disease].
    Timonen T, Möttönen M, Nousiainen T, Herva R, Savolainen ER.
    Duodecim; 2005; 121(19):2068-76. PubMed ID: 16300295
    [No Abstract] [Full Text] [Related]

  • 2. Giant lymphadenopathy infiltrated by gaucher cells mimicking lymphoma.
    Yağci B, Salor O, Yalçin B, Gürakan F, Güçer S, Büyükpamukçu M.
    Pediatr Blood Cancer; 2009 Jul; 52(7):870-1. PubMed ID: 19213078
    [Abstract] [Full Text] [Related]

  • 3. [Organization of Gaucher disease management in France].
    Stirnemann J, de Villemeur TB, Belmatoug N.
    Rev Med Interne; 2007 Oct; 28 Suppl 2():S198-201. PubMed ID: 18228688
    [Abstract] [Full Text] [Related]

  • 4. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy.
    Burrow TA, Cohen MB, Bokulic R, Deutsch G, Choudhary A, Falcone RA, Grabowski GA.
    J Pediatr; 2007 Feb; 150(2):202-6. PubMed ID: 17236903
    [Abstract] [Full Text] [Related]

  • 5. A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patients.
    Kraoua I, Sedel F, Caillaud C, Froissart R, Stirnemann J, Chaurand G, Flodrops H, Tari S, Gourfinkel-An I, Mathieu S, Belmatoug N, Billette de Villemeur T, Mignot C.
    Brain Dev; 2011 Feb; 33(2):131-9. PubMed ID: 20307947
    [Abstract] [Full Text] [Related]

  • 6. Enzyme, substrate, and myeloma in Gaucher disease.
    Hughes DA.
    Am J Hematol; 2009 Apr; 84(4):199-201. PubMed ID: 19291728
    [No Abstract] [Full Text] [Related]

  • 7. Gaucher disease: lessons from a decade of therapy.
    Grabowski GA.
    J Pediatr; 2004 May; 144(5 Suppl):S15-9. PubMed ID: 15126979
    [No Abstract] [Full Text] [Related]

  • 8. [Gaucher Disease].
    Okuyama T.
    Brain Nerve; 2015 Sep; 67(9):1109-13. PubMed ID: 26329151
    [Abstract] [Full Text] [Related]

  • 9. [Current therapeutic focus in type I Gaucher's disease].
    Pérez Calvo JI, Pastores GM, Isola L, Giraldo P, Bueno Gómez J.
    Sangre (Barc); 1994 Feb; 39(1):39-44. PubMed ID: 8197518
    [No Abstract] [Full Text] [Related]

  • 10. Parkinsonism among Gaucher disease carriers.
    Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E.
    J Med Genet; 2004 Dec; 41(12):937-40. PubMed ID: 15591280
    [Abstract] [Full Text] [Related]

  • 11. Congenital ichthyosis preceding neurologic symptoms in two sibs with type 2 Gaucher disease.
    Fujimoto A, Tayebi N, Sidransky E.
    Am J Med Genet; 1995 Nov 20; 59(3):356-8. PubMed ID: 8599361
    [Abstract] [Full Text] [Related]

  • 12. [Principles of diagnosis and the clinical course of 8 cases of Gaucher's disease (beta-glucocerebrosidase deficiency)].
    Tylki-Szymańska A, Maciejko D, Rujner J, Goryluk B, Pronicka E.
    Pediatr Pol; 1987 Jan 20; 62(1):9-18. PubMed ID: 3615053
    [No Abstract] [Full Text] [Related]

  • 13. New perspectives in type 2 Gaucher disease.
    Sidransky E.
    Adv Pediatr; 1997 Jan 20; 44():73-107. PubMed ID: 9265968
    [No Abstract] [Full Text] [Related]

  • 14. [Gaucher disease in childhood].
    Levrat V, Forest I, Fouilhoux A, Guffon N.
    Rev Med Interne; 2007 Oct 20; 28 Suppl 2():S183-6. PubMed ID: 18228686
    [Abstract] [Full Text] [Related]

  • 15. Non-neuronopathic Gaucher disease due to saposin C deficiency.
    Tylki-Szymańska A, Czartoryska B, Vanier MT, Poorthuis BJ, Groener JA, Ługowska A, Millat G, Vaccaro AM, Jurkiewicz E.
    Clin Genet; 2007 Dec 20; 72(6):538-42. PubMed ID: 17919309
    [Abstract] [Full Text] [Related]

  • 16. South African variants of Gaucher disease.
    Goldblatt J, Beighton P.
    Prog Clin Biol Res; 1982 Dec 20; 95():95-106. PubMed ID: 7122645
    [No Abstract] [Full Text] [Related]

  • 17. Variant Gaucher disease characterized by dysmorphic features, absence of cardiovascular involvement, laryngospasm, and compound heterozygosity for a novel mutation (D409H/C16S).
    Bodamer OA, Church HJ, Cooper A, Wraith JE, Scott CR, Scaglia F.
    Am J Med Genet; 2002 May 15; 109(4):328-31. PubMed ID: 11992489
    [Abstract] [Full Text] [Related]

  • 18. Gaucher disease of the Norrbottnian type (type III). Phenotypic manifestations.
    Svennerholm L, Dreborg S, Erikson A, Groth CG, Hillborg PO, Håkansson G, Nilsson O, Tibblin E.
    Prog Clin Biol Res; 1982 May 15; 95():67-94. PubMed ID: 6812091
    [No Abstract] [Full Text] [Related]

  • 19. Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene.
    Emre S, Gürakan F, Yüce A, Rolf A, Scott R, Ozen H.
    Eur J Med Genet; 2008 May 15; 51(4):315-21. PubMed ID: 18586596
    [Abstract] [Full Text] [Related]

  • 20. Recommendations on diagnosis, treatment, and monitoring for Gaucher disease.
    Martins AM, Valadares ER, Porta G, Coelho J, Semionato Filho J, Pianovski MA, Kerstenetzky MS, Montoril Mde F, Aranda PC, Pires RF, Mota RM, Bortolheiro TC, Brazilian Study Group on Gaucher Disease and other Lysosomal Storage Diseases.
    J Pediatr; 2009 Oct 15; 155(4 Suppl):S10-8. PubMed ID: 19765407
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.